Salla Keskitalo

Title: Salla Keskitalo: Innovator in Angiogenic Research

Introduction

Salla Keskitalo is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of angiogenic research, particularly through her innovative work on modified VEGF-A. Her research focuses on enhancing the properties of vascular endothelial growth factor, which plays a crucial role in blood vessel formation.

Latest Patents

Salla Keskitalo holds a patent for a modified VEGF-A with improved angiogenic properties. The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules of this invention retain VEGFR-2 binding activity and exhibit enhanced angiogenic activity compared to native VEGF-A. This advancement has the potential to impact therapeutic approaches in various medical fields.

Career Highlights

Keskitalo is associated with Vegenics Pty Limited, where she continues to develop her research and innovations. Her work has been instrumental in advancing the understanding of angiogenesis and its applications in medicine. With a patent portfolio that includes 1 patent, she is recognized for her contributions to the scientific community.

Collaborations

Salla has collaborated with notable researchers in her field, including Kari Alitalo and Tuomas Tammela. These collaborations have further enriched her research and expanded the impact of her innovations.

Conclusion

Salla Keskitalo is a key figure in the field of angiogenic research, with her innovative work on modified VEGF-A paving the way for future advancements. Her contributions are vital to the ongoing exploration of therapeutic applications in medicine.